Tatva Chintan Pharma Chem Share Price

NSE: TATVA
|
Chemicals

₹ 1,911.00

-₹29.60 (-1.53%)
1D
Last updated 15 Oct, 2026, 11:55 IST

Tatva Chintan Pharma Chem Share Price Today

As of 15 Oct 2026, Tatva Chintan Pharma Chem share price is ₹1,911.00. The stock opened at ₹1,931.00, compared to its previous close of ₹1,940.60. During today's trading session, Tatva Chintan Pharma Chem share price moved in the range of ₹1,882.00 to ₹1,958.00, with an average price of ₹1,920.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,044.10 and a high of ₹2,008.70. On the performance front, Tatva Chintan Pharma Chem share price has increased by 59.37% over the last six months and is up 76.35% on a year-on-year basis.

₹1,882.00
1.53% down today
₹1,958.00
1D LOW
1D HIGH

Tatva Chintan Pharma Chem Returns Calculator

Volume
41,794
Average traded price
₹1,903.30
Last traded time
11:55:22 15 Oct
Last traded quantity
5
Circuit
L
H
₹1,552.50
₹2,328.70
52-week
L
H
₹1,044.10
₹2,008.70
Mkt Cap Cr
4,547.77
P/E
88.49
P/B
5.82
ROA
5.12%
ROE
5.38%
ROCE
6.63%
Quick Ratio
0.72
EV/EBITDA
39.46
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Tatva Chintan outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Tatva Chintan appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Tatva Chintan revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Pidilite Industries1,52,271.7656.9114.0617.34%22.61%29.97%1.937.24
SRF73,809.7834.145.268.95%13.07%13.18%0.6820.36
Linde India51,243.9093.9312.039.41%12.87%17.16%0.7651.68
Gujarat Fluorochemicals50,509.0383.336.45.05%7.13%8.93%0.9737.98
Navin Fluorine43,445.0055.0210.9312.38%16.69%18.14%2.1934.39
Godrej Industries33,629.5315.223.011.75%11.1%9.34%0.3512.5
Himadri Speciality Chemicals33,294.3341.47.0712.75%15.96%19.45%1.6727.7
Aether Industries22,784.8096.889.287.35%8.94%10.61%0.9659.37
Deepak Nitrite22,108.6328.223.799.02%9.43%10.74%1.7317.14
Castrol India19,184.0318.7510.0646.22%46.94%71.77%1.2812.07

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Tatva Chintan Pharma Chem

ISIN
INE0GK401011
Sector Market Cap
₹ 4,547.77 Cr

Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are used for forming channels in zeolites. Its PTCs are used in heterogeneous multiphase systems, facilitating reactant migration. It operates through the Specialty chemical segment. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. It caters to various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.

Tatva Chintan Pharma Chem Financial Highlights

  • Revenue: Tatva Chintan Pharma Chem reported revenue of ₹509.41 crore in FY26 vs ₹385.03 crore in FY25. It showed an increase of 32.30% on a yearly basis.
  • Operating Profit: Tatva Chintan Pharma Chem reported an operating profit of ₹57.01 crore in FY26 vs ₹7.58 crore in FY25. It showed an increase of 652.11% on a year-on-year basis.
  • Net Profit: Tatva Chintan Pharma Chem reported a net profit of ₹42.05 crore in FY26 vs ₹5.71 crore in FY25. It showed an increase of 636.43% on a yearly basis.

Tatva Chintan Pharma Chem Quarterly Result Highlights

  • Tatva Chintan Pharma Chem reported revenue of ₹169.84 crore in Jun 2026, compared with ₹133.79 crore in Mar 2026, representing an increase of 26.95% on a quarter-on-quarter (QoQ) basis.
  • Tatva Chintan Pharma Chem reported an operating profit of ₹21.11 crore in Jun 2026, compared with ₹16.59 crore in Mar 2026, representing an increase of 27.25% on a quarter-on-quarter (QoQ) basis.
  • Tatva Chintan Pharma Chem reported a profit of ₹15.98 crore in Jun 2026, compared with ₹10.32 crore in Mar 2026, reflecting an increase of 54.84% on a QoQ basis.
  • The earnings per share (EPS) of Tatva Chintan Pharma Chem stood at ₹17.98 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.02%
FII
3.93%
Other DII
0.32%
Retail and other
20.94%
Mutual funds
2.79%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20253.39%
Dec 20254.17%
Mar 20263.82%
Jun 20263.93%
1 day
+5.39%
1 week
-2.54%
1 month
+20.63%
1 year
+76.35%
3 years
+24.73%
5 years
-16.57%
Day
Open / Close
Change %
14 Oct 26
₹1,841.30 / ₹1,940.60
+5.39%
13 Oct 26
₹1,875.00 / ₹1,841.30
-1.59%
12 Oct 26
₹1,820.00 / ₹1,871.10
+3.67%
09 Oct 26
₹1,850.10 / ₹1,804.80
-2.74%
Show more

Tatva Chintan Pharma Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹505.86₹382.71₹393.50₹423.61
Other Income₹3.55₹2.32₹7.51₹5.74
Total Revenue₹509.41₹385.03₹401.01₹429.36
Total Expenses₹452.40₹377.45₹357.45₹380.99
Profit Before Tax₹57.01₹7.58₹43.57₹44.78
Tax₹14.96₹1.87₹13.21-₹0.71
Profit After Tax₹42.05₹5.71₹30.35₹45.49
EPS - Basic₹17.98₹2.44₹13.26₹20.52
EPS - Diluted₹17.98₹2.44₹13.26₹20.52

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹57.01₹7.58₹43.57₹44.78
Income before WC changes₹101.09₹36.89₹72.17₹61.47
Change in Assets-₹87.03-₹2.76₹22.02-₹4.31
Change in Liabilities₹25.10-₹4.85₹12.42-₹20.09
Change in WC-₹61.93-₹7.62₹34.44-₹24.40
Cash flow from Operations₹31.49₹24.77₹98.04₹27.78
Cash flow from Investing-₹115.84-₹65.38-₹120.54-₹101.14
Cash flow from Financing₹78.93₹16.59₹30.52₹37.80
Total Cash Flow-₹5.42-₹24.02₹8.02-₹35.57
Cash (Start of the year)₹11.37₹35.30₹27.37₹63.02
Cash (End of the year)₹5.76₹11.37₹35.30₹27.37

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹654.18₹571.00₹520.81₹446.61
Current Assets₹349.51₹265.25₹297.91₹312.25
Total Assets₹1,003.69₹836.25₹818.72₹758.86
Current Liabilities₹213.14₹96.03₹79.66₹238.69
Net Current Asset₹136.38₹169.22₹218.24₹73.56
Non-Current Liabilities₹8.80₹1.40₹1.97₹5.38
Equity Capital₹781.76₹738.82₹737.08₹514.79
Total Equity & Liabilities₹1,003.69₹836.25₹818.72₹758.86

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹496.30₹366.42₹378.68₹403.04
Other Income₹3.53₹3.56₹7.51₹5.68
Total Revenue₹499.82₹369.98₹386.19₹408.72
Total Expenses₹446.66₹369.52₹343.92₹366.30
Profit Before Tax₹53.17₹0.46₹42.27₹38.83
Tax₹14.08₹0.13₹12.92-₹1.63
Profit After Tax₹39.08₹0.33₹29.35₹40.47
EPS - Basic₹16.71₹0.14₹12.82₹18.26
EPS - Diluted₹16.71₹0.14₹12.82₹18.26

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹53.17₹0.46₹42.27₹38.83
Income before WC changes₹94.46₹28.80₹70.44₹54.65
Change in Assets-₹96.15₹6.47₹24.54₹14.02
Change in Liabilities₹35.10-₹6.83₹14.27-₹37.20
Change in WC-₹61.06-₹0.35₹38.81-₹23.18
Cash flow from Operations₹29.17₹24.01₹102.78₹23.73
Cash flow from Investing-₹115.83-₹65.38-₹120.54-₹101.12
Cash flow from Financing₹78.93₹16.59₹30.54₹37.82
Total Cash Flow-₹7.74-₹24.78₹12.78-₹39.58
Cash (Start of the year)₹9.21₹33.99₹21.19₹60.78
Cash (End of the year)₹1.47₹9.21₹33.99₹21.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹653.43₹571.29₹521.46₹447.25
Current Assets₹341.95₹251.52₹293.61₹307.61
Total Assets₹995.38₹822.80₹815.07₹754.86
Current Liabilities₹228.35₹100.09₹87.21₹244.70
Net Current Asset₹113.60₹151.43₹206.39₹62.91
Non-Current Liabilities₹8.80₹1.40₹1.97₹5.38
Equity Capital₹758.23₹721.31₹725.88₹504.78
Total Equity & Liabilities₹995.38₹822.80₹815.07₹754.86
* All values are in INR Crore
Qty
Bid
9
1910.7
3
1909.3
1
1909.2
2
1909.1
1
1909
Ask
Qty
1910.9
50
1911
26
1912.5
4
1912.6
2
1912.8
2
Bid Total: 16
Ask Total: 84
Buy orders: 16%
Sell orders: 84%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
61.02
Neutral
ATR (14)
104.21
Neutral
STOCH(9,6)
79.1
Bearish
STOCH RSI (14)
44.32
Neutral
ADX(9)
27.96
Bearish
UO(9)
57.75
Neutral
ROC(12)
8.22
Bullish
WillR(14)
-20.9
Neutral
Period
Simple value
Exponential vaue
5D
1862.68
1880.02
10D
1850.84
1852.7
20D
1800.35
1806.71
50D
1718.94
1710.26
100D
1526.2
1587.96
Volume trend — traded volume by day
15 Oct0L
14 Oct1L
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Tatva Chintan Pharma Chem
Chemicals
Add Stock
Add Another

Tatva Chintan Pharma Chem Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.